0000950170-25-050478.txt : 20250403
0000950170-25-050478.hdr.sgml : 20250403
20250403163042
ACCESSION NUMBER: 0000950170-25-050478
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20250402
FILED AS OF DATE: 20250403
DATE AS OF CHANGE: 20250403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dooley Mary Beth
CENTRAL INDEX KEY: 0002015112
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 25810042
MAIL ADDRESS:
STREET 1: 301 BINNEY ST., SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PO BOX 30
CITY: WINCHESTER
STATE: MA
ZIP: 01890
BUSINESS PHONE: 617-659-2802
MAIL ADDRESS:
STREET 1: PO BOX 30
CITY: WINCHESTER
STATE: MA
ZIP: 01890
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
ownership.xml
4
X0508
4
2025-04-02
0001527599
SYNLOGIC, INC.
SYBX
0002015112
Dooley Mary Beth
C/O SYNLOGIC, INC.
PO BOX 30
WINCHESTER
MA
01890
false
true
false
false
See Remarks below
false
Common Stock
2025-04-02
4
S
false
144
1.2
D
12901
D
Represents the number of shares sold by the reporting person on April 2, 2025 to cover the tax liability in connection with the vesting of three restricted stock awards, vesting on April 1, 2025, that were granted in 2021, 2022 and 2023.
Principal Executive Officer and Principal Financial Officer
/s/ Mary Beth Dooley
2025-04-03